Personalized medicine and the role of induced pluripotent stem cells

Cardiovascular Research

Volumn 95, Issue 4, 2012, Pages 395-396

  Van Der Heyden, Marcel A G ^a   Jonsson, Malin K B ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Arvid Wallgrens Backe 20   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNQ1; PROPRANOLOL;

CARDIAC PATIENT; CLINICAL PRACTICE; EDITORIAL; ELECTROCARDIOGRAM; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HEART ARREST; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART REPOLARIZATION; HUMAN; HUMAN GENOME; LONG QT SYNDROME; PERSONALIZED MEDICINE; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QT PROLONGATION; SKIN BIOPSY;

ANIMALS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MYOCYTES, CARDIAC; ROMANO-WARD SYNDROME;

EID: 84865243709     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs242     Document Type: Editorial

References (12)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282: 1145-1147.
2. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131: 861-872.
3. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318:1917-1920.
4. Lin B, Kim J, Li Y, Pan H, Carvajal-Vergara X, Salama G et al. High-purity enrichment of functional cardiovascular cells from human iPS cells. Cardiovasc Res 2012;95: 327-335.
5. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012;485: 593-598.
6. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009;461:402-406.
7. Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flügel L et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010; 363:1397-1409.
8. Oh Y, Wei H, Ma D, Sun X, Liew R. Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine. Heart 2012;6: 443-449.
9. Egashira T, Yuasa S, Suzuki T, Aizawa Y, Yamakawa H, Matsuhashi T et al. Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc Res 2012;95:419-429.
10. Van der Heyden MA, Smits ME, Vos MA. Drugs and trafficking of ion channels: a new pro-arrhythmic threat on the horizon? Br J Pharmacol 2008;153: 406-409.
11. Wolinsky H. The thousand-dollar genome: genetic brinkmanship or personalized medicine? EMBO Rep 2007;8:900-903.
12. Kedes L, Campany G. The new date, new format, new goals and new sponsor of the Archon Genomics X PRIZE competition. Nat Genet 2011;43:1055-1058.